To verify the specificity of the CAIX1 and CAIX4 nanobodies, immunofluorescence studies were performed using co-cultures of CAIX-overexpressing (DCIS + CAIX) and CAIX negative (DCIS) MCF10DCIS cells. This evidence concerns the gene CA9 and ductal breast carcinoma in situ.